Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium.

Birmann BM, Neuhouser ML, Rosner B, Albanes D, Buring JE, Giles GG, Lan Q, Lee IM, Purdue MP, Rothman N, Severi G, Yuan JM, Anderson KC, Pollak M, Rifai N, Hartge P, Landgren O, Lessin L, Virtamo J, Wallace RB, Manson JE, Colditz GA.

Blood. 2012 Dec 13;120(25):4929-37. doi: 10.1182/blood-2012-03-417253. Epub 2012 Oct 16. Erratum in: Blood. 2014 Sep 11;124(11):1845-7.

PMID:
23074271
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma.

Birmann BM, Tamimi RM, Giovannucci E, Rosner B, Hunter DJ, Kraft P, Mitsiades C, Anderson KC, Colditz GA.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):282-8. doi: 10.1158/1055-9965.EPI-08-0778.

PMID:
19124510
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

[Analysis of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and multiple myeloma].

Scudla V, Budíková M, Petrová P, Minarík J, Pika T, Bacovský J, Adamová D, Langová K; Ceská myelomová skupina.

Klin Onkol. 2010;23(3):171-81. Czech.

PMID:
20608327
[PubMed - indexed for MEDLINE]
4.

Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.

Douglas JB, Silverman DT, Pollak MN, Tao Y, Soliman AS, Stolzenberg-Solomon RZ.

Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2298-306. doi: 10.1158/1055-9965.EPI-10-0400. Epub 2010 Aug 10.

PMID:
20699371
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: biological insights and early treatment strategies.

Landgren O.

Hematology Am Soc Hematol Educ Program. 2013;2013:478-87. doi: 10.1182/asheducation-2013.1.478. Review.

PMID:
24319222
[PubMed - indexed for MEDLINE]
Free Article
6.

Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.

Molica S, Vitelli G, Mirabelli R, Digiesu G, Giannarelli D, Cuneo A, Ribatti D, Vacca A.

Eur J Haematol. 2006 Jan;76(1):51-7.

PMID:
16343271
[PubMed - indexed for MEDLINE]
7.

Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).

Tsilidis KK, Travis RC, Appleby PN, Allen NE, Lindström S, Albanes D, Ziegler RG, McCullough ML, Siddiq A, Barricarte A, Berndt SI, Bueno-de-Mesquita HB, Chanock SJ, Crawford ED, Diver WR, Gapstur SM, Giovannucci E, Gu F, Haiman CA, Hayes RB, Hunter DJ, Johansson M, Kaaks R, Kolonel LN, Kraft P, Le Marchand L, Overvad K, Polidoro S, Riboli E, Schumacher FR, Stevens VL, Trichopoulos D, Virtamo J, Willett WC, Key TJ.

Int J Cancer. 2013 Jul 15;133(2):495-504. doi: 10.1002/ijc.28042. Epub 2013 Feb 15.

PMID:
23341348
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma.

Filella X, Blade J, Guillermo AL, Molina R, Rozman C, Ballesta AM.

Cancer Detect Prev. 1996;20(1):52-6.

PMID:
8907203
[PubMed - indexed for MEDLINE]
9.

Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era.

Platz EA, Pollak MN, Leitzmann MF, Stampfer MJ, Willett WC, Giovannucci E.

Cancer Causes Control. 2005 Apr;16(3):255-62.

PMID:
15947877
[PubMed - indexed for MEDLINE]
10.

[The significance of IGF-1, VEGF, IL-6 in multiple myeloma progression].

Guo YQ, Chen SL.

Zhonghua Xue Ye Xue Za Zhi. 2006 Apr;27(4):231-4. Chinese.

PMID:
16875552
[PubMed - indexed for MEDLINE]
11.

Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.

Woodson K, Tangrea JA, Pollak M, Copeland TD, Taylor PR, Virtamo J, Albanes D.

Cancer Res. 2003 Jul 15;63(14):3991-4.

PMID:
12873996
[PubMed - indexed for MEDLINE]
Free Article
12.

Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: A nested case-control study in large scale cohort study in Japan.

Mikami K, Ozasa K, Nakao M, Miki T, Hayashi K, Watanabe Y, Mori M, Sakauchi F, Washio M, Kubo T, Suzuki K, Wakai K, Nakachi K, Tajima K, Ito Y, Inaba Y, Tamakoshi A; JACC Study Group.

Asian Pac J Cancer Prev. 2009 Dec;10 Suppl:57-61.

PMID:
20553083
[PubMed - indexed for MEDLINE]
Free Article
13.

Insulin-like growth factor I and risk of breast cancer by age and hormone receptor status-A prospective study within the EPIC cohort.

Kaaks R, Johnson T, Tikk K, Sookthai D, Tjønneland A, Roswall N, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Dossus L, Rinaldi S, Romieu I, Boeing H, Schütze M, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Grioni S, Tumino R, Sacerdote C, Panico S, Buckland G, Argüelles M, Sánchez MJ, Amiano P, Chirlaque MD, Ardanaz E, Bueno-de-Mesquita HB, van Gils CH, Peeters PH, Andersson A, Sund M, Weiderpass E, Gram IT, Lund E, Khaw KT, Wareham N, Key TJ, Travis RC, Merritt MA, Gunter MJ, Riboli E, Lukanova A.

Int J Cancer. 2014 Jun 1;134(11):2683-90. doi: 10.1002/ijc.28589. Epub 2013 Nov 19.

PMID:
24248481
[PubMed - indexed for MEDLINE]
14.

Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor.

Standal T, Borset M, Lenhoff S, Wisloff F, Stordal B, Sundan A, Waage A, Seidel C.

Blood. 2002 Dec 1;100(12):3925-9. Epub 2002 Jul 18.

PMID:
12393395
[PubMed - indexed for MEDLINE]
Free Article
15.

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.

Stattin P, Bylund A, Rinaldi S, Biessy C, Déchaud H, Stenman UH, Egevad L, Riboli E, Hallmans G, Kaaks R.

J Natl Cancer Inst. 2000 Dec 6;92(23):1910-7.

PMID:
11106682
[PubMed - indexed for MEDLINE]
Free Article
16.

Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer.

Harman SM, Metter EJ, Blackman MR, Landis PK, Carter HB; Baltimore Longitudinal Study on Aging.

J Clin Endocrinol Metab. 2000 Nov;85(11):4258-65.

PMID:
11095464
[PubMed - indexed for MEDLINE]
17.

Insulin-like growth factor 1, insulin-like growth factor-binding protein 3, and testicular germ-cell tumor risk.

Chia VM, Quraishi SM, Graubard BI, Rubertone MV, Erickson RL, Stanczyk FZ, McGlynn KA.

Am J Epidemiol. 2008 Jun 15;167(12):1438-45. doi: 10.1093/aje/kwn080. Epub 2008 Apr 11.

PMID:
18408226
[PubMed - indexed for MEDLINE]
Free Article
18.

The importance of serum levels of selected biological parameters in the diagnosis, staging and prognosis of multiple myeloma.

Scudla V, Pika T, Budikova M, Petrova J, Minarik J, Bacovsky J, Langova K, Zivna J; Czech Myeloma Group.

Neoplasma. 2010;57(2):102-10.

PMID:
20099972
[PubMed - indexed for MEDLINE]
19.

Analysis of the serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and different stages of multiple myeloma.

Scudla V, Petrova P, Minarik J, Pika T, Bacovsky J.

Neoplasma. 2011;58(6):499-506.

PMID:
21895403
[PubMed - indexed for MEDLINE]
20.

Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.

Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X, Anderson GL, Kaplan RC, Harris TG, Howard BV, Wylie-Rosett J, Burk RD, Strickler HD.

J Natl Cancer Inst. 2009 Jan 7;101(1):48-60. doi: 10.1093/jnci/djn415. Epub 2008 Dec 30.

PMID:
19116382
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk